BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36855960)

  • 1. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States.
    Turakhia MP; Guo JD; Keshishian A; Delinger R; Sun X; Ferri M; Russ C; Cato M; Yuce H; Hlavacek P
    Clin Cardiol; 2023 May; 46(5):484-493. PubMed ID: 36855960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated prevalence of undiagnosed atrial fibrillation in the United States.
    Turakhia MP; Shafrin J; Bognar K; Trocio J; Abdulsattar Y; Wiederkehr D; Goldman DP
    PLoS One; 2018; 13(4):e0195088. PubMed ID: 29649277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.
    Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
    Circ J; 2019 Nov; 83(12):2547-2554. PubMed ID: 31619594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.
    Redfors B; Gray WA; Lee RJ; Ellenbogen KA; Bonafede M; Ben-Yehuda O
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1369-1376. PubMed ID: 29759666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.
    Singer DE; Atlas SJ; Go AS; Lopes RD; Lubitz SA; McManus DD; Revkin JH; Mills D; Crosson LA; Lenane JC; Aronson RS
    Am Heart J; 2022 Jul; 249():76-85. PubMed ID: 35472303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
    Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
    Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
    Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
    PLoS One; 2022; 17(2):e0263903. PubMed ID: 35176074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
    J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and Systemic Thromboembolism according to CHA
    Lee KB; Kim TH; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Lee YS; Shim J; Joung B
    Yonsei Med J; 2022 Apr; 63(4):317-324. PubMed ID: 35352882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
    Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
    J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
    Abdel-Qadir H; Singh SM; Pang A; Austin PC; Jackevicius CA; Tu K; Dorian P; Ko DT
    JAMA Cardiol; 2021 Aug; 6(8):918-925. PubMed ID: 34009232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
    Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
    Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.